The Office of Financial Sanctions Implementation has further expanded the reach of sanctions in respect of Belarus to cover an additional 40 individuals. These 40 individuals have been designated at EU level and added to the consolidated list. Five of these individuals were previously sanctioned under the United Kingdom's global human rights regime and are now subject to an asset freeze under both this regime and the EU regime.
The Office of Financial Sanctions Implementation recently announced that eight Belarusian officials have been subjected to sanctions (asset freezes and travel bans) under the United Kingdom's autonomous global human rights sanctions regime. This regime was introduced earlier in 2020 as a 'Magnitsky-style' regime and is the first autonomous sanctions regime adopted by the United Kingdom following its departure from the European Union.
The Department for International Trade recently announced that the United Kingdom has taken a major step in the process of joining the Comprehensive and Progressive Agreement for Trans-Pacific Partnership, one of the world's largest and most dynamic free trade areas. The partnership includes ambitious agreements on digital trade, data, financial, professional and business services, all of which are areas where the United Kingdom is a global leader and stands to benefit from more trade.
The COVID-19 pandemic has led to a significant expansion in the need for telehealth, with as many patient visits as possible being conducted using telehealth platforms. As a result, healthcare providers must meet patient needs while at the same time meeting data protection regulatory requirements under the Health Insurance Portability and Accountability Act. This video discusses the recent changes to the telehealth sector and what healthcare providers need to do to ensure that they comply with data regulations.
The US Food and Drug Administration recently issued its draft guidance on clinical research for the development of drugs that contain cannabis or cannabis-derived compounds of botanical origin (as opposed to synthetic). The guidance provides some clarity on the use of cannabis in clinical research in light of the changes made by the Agriculture Improvement Act 2018, which federally legalised hemp and derivatives that contain no more than 0.3% by dry weight of THC.
The consequences of supply chain interruptions from a compliance perspective vary slightly, depending on the type of product and its indication. Human drug products and medical device products have different requirements for reporting supply chain disruptions and the impact of COVID-19 has cast a bright light on this inequity. Compliance with reporting requirements is therefore paramount during the ongoing pandemic.